CODS - Journal of Dentistry

Register      Login

VOLUME 13 , ISSUE 1 ( January-June, 2021 ) > List of Articles


Surface Persistence of SARS-CoV-1 MERS and SARS-CoV-2 Viruses and Effective Biocidal Agents: An Insight

Agami Mehta, Vandana Laxman

Keywords : Biocidal, Coronavirus, Disinfection, Persistence surface, Survival skin, Survival surface

Citation Information : Mehta A, Laxman V. Surface Persistence of SARS-CoV-1 MERS and SARS-CoV-2 Viruses and Effective Biocidal Agents: An Insight. CODS J Dent 2021; 13 (1):18-23.

DOI: 10.5005/jp-journals-10063-0083

License: CC BY-NC 4.0

Published Online: 27-12-2021

Copyright Statement:  Copyright © 2021; The Author(s).


The novel coronavirus disease is the ongoing pandemic that is caused by severe acute respiratory syndrome coronavirus or SARS-CoV-2. The disease continues to create havoc globally and has created fears in the mind of individuals regarding its spread and transmission. Transmission among humans occur through close contact with an infected individual who may produce respiratory droplets while coughing and sneezing which can remain in air and/or settle on inanimate objects. Therefore, knowledge about the persistence of the virus on various surfaces helps in alleviating irrational fears and also aids in controlling the spread of infection. In this review, an effort was made to compile the data on the persistence of the human coronaviruses such as SARS-CoV-1, Middle East respiratory syndrome (MERS), and SARS-Cov-2 on various surfaces and the biocidal agents that are effective against them.

  1. Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020;75:1730–1741. DOI: 10.1111/all.14238
  2. Ghinai I, McPherson TD, Hunter JC, et al. First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA. Lancet 2020;395:P1137–P1144. DOI:
  3. Kampf G, Todt D, Pfaender S, et al. Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents. J Hospital Infect 2020;104:246–251. DOI: 10.1016/j.jhin.2020.01.022
  4. Ather A, Patel B, Ruparel NB, et al. Coronavirus disease 19 (COVID-19): implications for clinical dental care. J Endodont 2020;46:584–595. DOI: 10.1016/j.joen.2020.03.008
  5. Ahorsu DK, Lin CY, Imani V, et al. The fear of COVID-19 scale: development and initial validation. Int J Ment Health Addict 2020;27:1–9. DOI: 10.1007/s11469-020-00270-8
  6. Van Doremalen N, Bushmaker T, Morris DH, et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. NEngl J Med. 2020;382(16):1564–1567. DOI: 10.13039/100006492
  7. Warnes SL, Little ZR, Keevil CW. Human coronavirus 229E remains infectious on common touch surface materials. MBio 2015;6(6):e01697–15. DOI:
  8. Van Doremalen N, Bushmaker T, Munster VJ. Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions. Euro Surveill 2013;18(38):20590. DOI: 10.2807/1560-7917.es2013.18.38.20590
  9. Sizun J, Yu MW, Talbot PJ. Survival of human coronaviruses 229E and OC43 in suspension and after drying onsurfaces: a possible source ofhospital-acquired infections. J Hosp Infect 2000;46(1):55–60. DOI: 10.1053/jhin.2000.0795
  10. Duan SM, Zhao XS, Wen RF, et al. Stability of SARS coronavirus in human specimens and environment and its sensitivity to heating and UV irradiation. Biomed Environ Sci 2003;16:246–255.
  11. Lai MY, Cheng PK, Lim WW. Survival of severe acute respiratory syndrome coronavirus. Clin Infect Dis 2005;41(7):e67–e71. DOI: 10.1086/433186
  12. Chan KH, Peiris JM, Lam SY, et al. The effects of temperature and relative humidity on the viability of the SARS coronavirus. Adv Virol 2011;2011. DOI: 10.1155/2011/734690
  13. Rabenau HF, Cinatl J, Morgenstern B, et al. Stability and inactivation of SARS coronavirus. Med Microbiol Immunol 194(1-2):1–6.
  14. Siddharta A, Pfaender S, Vielle NJ, et al. Virucidal activity ofization–recommended formulations against enveloped viruses, including zika, ebola, and emerging coronaviruses. J Infect Dis 2017;215(6):902–906. DOI: 10.1093/infdis/jix046
  15. Omidbakhsh N, Sattar SA. Broad-spectrum microbicidal activity, toxicologic assessment, and materials compatibility of a new generation of accelerated hydrogen peroxide-based environmental surface disinfectant. Am J Infect Control 2006;34(5):251–257. DOI: 10.1016/j.ajic.2005.06.002.
  16. Kariwa H, Fujii N, Takashima I. Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions and chemical reagents. Dermatology 2006;212(Suppl. 1):119–123. DOI: 10.1159/000089211
  17. Eggers M, Koburger-Janssen T, Eickmann M, et al. In vitro bactericidal and virucidal efficacy of povidone-iodine gargle/mouthwash against respiratory and oral tract pathogens. Infect Dis Ther. 2018;7(2):249–259. DOI: 10.1007/s40121-018-0200-7
  18. Eggers M, Eickmann M, Zorn J. Rapid and effective virucidal activity of povidone-iodine products against Middle East respiratory syndrome coronavirus (MERS-CoV) and modified vaccinia virus Ankara (MVA). Infect Dis Ther 2015;4(4):491–501. DOI: 10.1007/s40121-015-0091-9
  19. Saxena SK, ed. Coronavirus Disease 2019 (COVID-19): Epidemiology, Pathogenesis, Diagnosis, and Therapeutics. Springer Nature; 2020
  20. Walls AC, Park YJ, Tortorici MA, et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181:281.e6–292.e6. DOI: 10.1016/j.cell.2020.02.058
  21. Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260–1263. DOI: 10.13039/100000060.
  22. Kumar S, Maurya VK, Prasad AK, et al. Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV). Virusdisease. 2020;31:13–21.
  23. Petrosillo N, Viceconte G, Ergonul O, et al. COVID-19, SARS and MERS: are they closely related? Clin Microbiol Infect 2020;26:729–734. DOI: 10.1016/j.cmi.2020.03.026
  24. World Health Organization. Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected: interim guidance, 25 January 2020
  25. Saknimit M, Inatsuki I, Sugiyama Y, et al. Virucidal efficacy of physico-chemical treatments against coronaviruses and parvoviruses of laboratory animals. Jikken Dobutsu 1988;37(3):341–345. DOI: 10.1538/expanim1978.37.3_341
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.